Navigation Links
Thrombotic in Medical News

Effient(TM) is Now Available in Pharmacies

...ed Effient tablets on July 10 for the reduction of thrombotic cardiovascular events (including stent thrombosis)...us for Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, ...ng statements about Effient for the reduction of thrombotic cardiovascular events (including stent thrombosis)...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...ents Over the Last Three Months The U.S. Food and Drug Administration (FDA) approved Effient((TM)) (prasugrel) tablets for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndromes who are managed with an artery-opening procedure known as...

Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)

...fient(TM) (prasugrel) tablets for the reduction of thrombotic cardiovascular events (including stent thrombosis)...ew option that provides greater protection against thrombotic cardiovascular events to help those suffering with...us for Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, ...

NCCN Updates Supportive Care Guidelines for VTE

...tment for patients with central DVT who are tolerating anticoagulation treatment. For patients in high-risk settings (e.g. those receiving highly thrombotic antiangiogenic therapy), the NCCN Guidelines strengthened the recommendation for VTE prophylaxis from 'consider' to 'recommend'. For patients with act...

New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia

...e cautiously in patients at risk for aspiration pneumonia. Priapism has been reported. Severe priapism may require surgical intervention. thrombotic Thrombocytopenic Purpura (TTP) has been reported. Administration: Care should be taken to avoid inadvertent injection into a blood vessel. ...

FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder

...e cautiously in patients at risk for aspiration pneumonia. Priapism has been reported. Severe priapism may require surgical intervention. thrombotic Thrombocytopenic Purpura (TTP) has been reported. Administration: Care should be taken to avoid inadvertent injection into a blood vessel. ...

Exercise Physiologist and Celebrity Trainer Bob Greene Leads National Campaign to Showcase Osteoarthritis Pain Management Techniques and New Treatment Approaches

...matory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk m.... With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs caus...

CMEFirst Presents State-of-the-Art Arthritis CME Symposium

... Whelton cautioned that the resulting destabilization of blood pressure control during this drug-drug interaction may contribute to the development of thrombotic cardiovascular complications during the long-term use of NSAIDs in patients who are being treated for hypertension. The next presenter, William ...

ViroPharma to Host Investor 'Teach-In' Educational Symposium on Hereditary Angioedema

..., rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood o...

ESC reaffirms advice on cardiovascular risks associated with long-haul flights

... or stroke) and those with heart failure, atrial fibrillation, and physical immobilisation." Professor Huber adds that even healthy people may develop thrombotic problems on a long-distance flight, notably pregnant women, women taking oral contraceptives (especially if they smoke) and the elderly. Those with co...
Thrombotic in Medical Technology

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

...velopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or athe...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

..., rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood o...

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

...atient who had previously presented with a subacute thrombosis and who was on dual antiplatelet therapy at the time of both thromboses. There were no thrombotic events in the Genous treated group at any time period (0.0%). Myocardial infarctions (MI) increased from years one to two in the Taxus patients to 6...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

...e cautiously in patients at risk for aspiration pneumonia. Priapism has been reported. Severe priapism may require surgical intervention. thrombotic Thrombocytopenic Purpura (TTP) has been reported. Administration: Care should be taken to avoid inadvertent injection into a blood vessel. ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

...lopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or ather...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

...lopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or ather...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

...lopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or ather...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

...ylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis o...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

...ylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis o...

Schering-Plough Announces Results of the Early ACS Trial

...nt ischemia requiring urgent revascularization, or thrombotic bailout through 96 hours. The secondary endpoint w...continued unchanged for 18-24 hours post-PCI. If a thrombotic complication occurred after the wire crossed the l...nt ischemia requiring urgent revascularization, or thrombotic bailout through 96 hours. The key secondary effica...
Thrombotic in Medical Products

Specialized Coagulation Testing

Description:... Machaon Diagnostics is a clinical reference laboratory, specializing in the diagnosis, treatment and monitoring of hemostatic and thrombotic conditions. Started as a collaboration of four laboratory scientists, Machaon Diagnostics has a defined vision to deliver customizable reference lab t...
Company:Machaon Diagnostics

Coatest APC Resistance Kit

Description:...se to activated protein C (APC). The test result (APC ratio) gives an estimation of the anticoagulant function in vivo and provides information on the thrombotic risk associated with inherited and acquired APC resistance. Detects the APC resistance phenotype regardless of its cause. Detects both inherited and a...
Company:DiaPharma Group, Inc.
Thrombotic in Medical Dictionary

Thrombocytopenia

...health information. ... Thrombocytopenia is an abnormally low level of platelets in the blood. ... thrombocytopenia . thrombocytopenic purpura. thrombotic thrombocytopenic purpura ... diseases can cause thrombocytopenia . Thrombocytopenia can occur when the ... Thrombocytopenia has various cau...

Protein C

...nto activated protein C (APC). The activated form degrades Factor Va and... Protein C deficiency is a rare genetic trait that predisposes to thrombotic disease. It was first described in 1981. The disease belongs to a group of genetic disorders known as thrombophilias. The prevalence of prote...

Hypercoagulable states

...ions that ... Hypercoagulable states are conditions that may lead to the abnormal ... The primary hypercoagulable states are inherited thrombotic disorders, resulting ... The acquired or secondary hypercoagulable states consist of a heterogeneous ... Inherited Hypercoagulable States ....

Hus

...long to remember: ... In TTP- HUS , thrombi caused by clumps of platelets block small blood vessels. ... Hemolytic-uremic syndrome ( HUS ) and thrombotic thrombocytopenic purpura (TTP) ... Home " HUS /TTP " Overview, Causes and Risk Factors, Symptoms, Diagnosis, Treatment ... HUS symptoms, caus...
Thrombotic in Biological News

OHSU turns innovations into commercial opportunities at record pace

...ed four companies. His most recent venture, Revitus, was focused on developing two novel extended-release drug compounds for preventing heart attacks, thrombotic strokes and death in patients who are at risk of adverse cardiovascular events. Revitus was acquired earlier this year by BioVascular, Inc., a private...

High-dose anticlotting drug cuts heart attack, death risk in half

...ant professor of cardiology at the University of Turin, in Turin, Italy. "The goal of antithrombotic management for PCI is to maximize protection from thrombotic complications during and shortly after PCI, while minimizing bleeding and costs." Clopidogrel interferes with the action of platelet cells, which...
Thrombotic in Biological Technology

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

..., rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood o...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

...t of novel drugs that enrich the quality of life for patients around the world. Areas of central focus for Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or ather...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

..., rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood o...

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients

...nted 30 day follow up with only one patient (0.2%) having a stent thrombosis. Suryapranata commented, "This rate is impressively low given the highly thrombotic environment associated with AMI patients." Longer term follow up is ongoing. Juan F Granada, MD, medical director of the Skirball Center for Car...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

...n ADAMTS13, an enzyme that processes von Willebrand factor, as the cause of thrombotic Thrombocytopenia Purpura. The laboratory is also searching for genetic modifiers of thrombotic diseases, including the common human mutation Factor V Leiden. Studies of ...

European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

...lopment of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or athe...

Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients

... viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. Components used in the packaging of this product are latex-free. thrombotic events have been reported in association with IGIV. Patients at risk may include those with a history of atherosclerosis, multiple cardiovascular risk...

MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008

... his experience with the MGuard(TM), Dr. Dudek stated: "We performed direct stenting on a patient with an acute myocardial infarction and a very large thrombotic lesion. We used an MGuardTM stent which covered the entire thrombus, preventing defragmentation and massive embolization. The final result was very go...

Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results

...tigational new drug (IND) application for PCI-27483, a small molecule inhibitor of Factor VIIa being developed both for the treatment of thrombotic complications of cancer and as an anti-cancer agent. * Plan to complete enrollment and evaluation of a Phase 1 trial in normal volu...

Vista Partners Initiates Coverage on MediciNova Inc. (Nasdaq: MNOV)

...is, solid tumor cancers, Generalized Anxiety Disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. MediciNova's current strategy is to focus its resources on the development and commercialization of two prioritized assets in its developme...
Thrombotic in Biological Dictionary

Dimer

...roducts (FDP); Prothrombin ... Why get the D-dimer test, which tests for thrombotic diseases and conditions; when to get D-dimer for thrombotic diseases and conditions The d-Dimer test, which is used to rule out bloo...
Other Tags
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
(Date:1/22/2015)... Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of ... of its new website design. "When we launched ... says Peter O,Neill , founder and CEO of FindBiometrics. ... needs involvement from the key players on a very broad ...
(Date:1/22/2015)... Jan. 15, 2015  BellBrook Labs, a leader in ... the launch of a TR-FRET (time resolved Forster ... UDP Assay, a high throughput screening assay for ... will allow for sensitive detection of hundreds of ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... technology and tech stocks, releases video from the CES 2015 ... security consultant Apollo Robbins . Apollo shows ... Wocket™ biometric smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
Other Contents